United Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	21,855	21,265	15,818	10,344	12,801	9,741
Market Cap Growth	32.15%	34.43%	52.93%	-19.20%	31.41%	44.27%
Enterprise Value	17,195	18,345	12,851	8,050	10,762	8,610
Last Close Price	498.65	487.25	352.84	219.89	278.09	216.08
PE Ratio	17.90	17.49	14.32	11.10	18.54	21.48
Forward PE	17.69	17.14	12.17	9.93	13.57	13.45
PEG Ratio	1.95	4.43	1.02	13.47	1.03	0.72
PS Ratio	6.87	6.68	5.50	4.44	6.61	5.78
PB Ratio	3.07	3.00	2.45	1.73	2.67	2.46
P/TBV Ratio	3.37	3.29	2.66	1.83	2.81	2.58
P/FCF Ratio	21.00	20.43	14.64	13.84	19.29	20.40
P/OCF Ratio	14.00	13.62	11.92	10.58	15.95	16.28
EV/Sales Ratio	5.40	5.76	4.47	3.46	5.56	5.11
EV/EBITDA Ratio	10.74	11.62	8.87	6.50	10.44	14.21
EV/EBIT Ratio	11.35	12.29	9.33	6.79	10.99	15.49
EV/FCF Ratio	16.52	17.63	11.89	10.77	16.22	18.04
Debt / Equity Ratio	-	0	0.05	0.12	0.17	0.20
Debt / EBITDA Ratio	-	-	0.21	0.56	0.78	1.32
Debt / FCF Ratio	-	-	0.28	0.94	1.21	1.68
Net Debt / Equity Ratio	-0.41	-0.41	-0.46	-0.38	-0.42	-0.29
Net Debt / EBITDA Ratio	-1.85	-1.85	-2.05	-1.85	-1.98	-1.87
Net Debt / FCF Ratio	-2.81	-2.81	-2.75	-3.07	-3.07	-2.37
Asset Turnover	0.42	0.42	0.40	0.35	0.35	0.34
Inventory Turnover	2.25	2.25	2.30	2.41	1.55	1.36
Quick Ratio	5.83	5.83	4.80	4.07	8.91	6.97
Current Ratio	6.60	6.60	5.25	4.41	9.85	7.61
Return on Equity (ROE)	19.71%	19.71%	19.23%	18.27%	16.61%	12.94%
Return on Assets (ROA)	15.25%	15.25%	14.72%	13.86%	13.37%	9.10%
Return on Invested Capital (ROIC)	28.26%	28.26%	28.04%	26.73%	24.82%	15.75%
Return on Capital Employed (ROCE)	21.41%	21.41%	21.20%	19.64%	18.55%	12.14%
Earnings Yield	6.11%	5.72%	6.98%	9.01%	5.39%	4.66%
FCF Yield	4.76%	4.89%	6.83%	7.23%	5.18%	4.90%
Buyback Yield / Dilution	3.84%	3.84%	5.31%	-1.01%	-0.74%	-0.57%

Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q